Tracking Cancer Over Time: ONCOVALUE’s Unique Annotated Dataset
ONCOVALUE has developed a unique annotated dataset to train an AI-based imaging tool designed to support the assessment of metastatic breast cancer. With Siemens Healthineers leading its development, the tool ultimately aims to help evaluate which therapies are effective by providing objective, image-based information on disease progression. Using longitudinal medical imaging data (i.e. imaging data […]
ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster
We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI). The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims […]
ONCOVALUE opens call for expressions of interest to participate in project’s validation activities
ONCOVALUE is a consortium of cancer institutes and commercial businesses that are working together to implement value-based oncology care by enabling and guiding cancer hospitals to collect, harmonize and analyse high-quality Real-World Data (RWD) in real-time, supporting cost-effectiveness evaluation of novel cancer therapies. The project is funded by the European Union under the call ‘HORIZON-HLTH […]